• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚酰胺-胺(PAMAM)树枝状大分子对灯盏花素溶解度和药代动力学的影响

[The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].

作者信息

Lu Jun-Jun, Wu Zheng-Hong, Ping Qi-Neng

机构信息

Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Yao Xue Xue Bao. 2009 Feb;44(2):197-202.

PMID:19408693
Abstract

To study the solubilization of breviscapine with polyamidoamine (PAMAM) dendrimers and probe the solubilizing mechanism and investigate the influence of PAMAM dendrimers on the pharmacokinetics of breviscapine, the solubilization of breviscapine by PAMAM dendrimers of generations G1, G1.5, G2 and G2.5 with different concentrations were determined and compared in different pH conditions. Twelve rats randomized into 2 groups were separately orally administered breviscapine and breviscapine combining with PAMAM. Drug in plasma was extracted and determined with HPLC. In pH condition lower than 7.0, the solubilization of breviscapine by PAMAM dendrimers enhanced as the generation and concentration of PAMAM dendrimers as well as the pH increased. Its solubilizing mechanism involves an electrostatic interaction between the carboxyl group of breviscapine and the primary amines and tertiary amines of PAMAM dendrimers. The pharmacokinetics parameters Cmax and AUC0-8 h of breviscapine were (119.65 +/- 9.36) ng x mL(-1) and (370.09 +/- 63.08) ng x h x mL(-1). For breviscapine combined with PAMAM dendrimers, the Cmax and AUC0-8 h were (518.17 +/- 17.07) ng x mL(-1) and (1,219.47 +/- 201.87) ng x h x mL(-1), respectively. There were significant differences of AUC0-8 h between breviscapine and breviscapine combined with PAMAM dendrimers (P < 0.01). PAMAM dendrimers can greatly increase the solubility of breviscapine in water and can improve the oral bioavailability of breviscapine significantly.

摘要

为研究灯盏花素与聚酰胺-胺(PAMAM)树枝状大分子的增溶作用,探究其增溶机制,并考察PAMAM树枝状大分子对灯盏花素药代动力学的影响,测定并比较了不同浓度的第G1、G1.5、G2和G2.5代PAMAM树枝状大分子在不同pH条件下对灯盏花素的增溶作用。将12只大鼠随机分为2组,分别口服灯盏花素以及灯盏花素与PAMAM树枝状大分子的混合物。血浆中的药物经提取后用高效液相色谱法测定。在pH低于7.0的条件下,PAMAM树枝状大分子对灯盏花素的增溶作用随着PAMAM树枝状大分子的代数、浓度以及pH的升高而增强。其增溶机制涉及灯盏花素的羧基与PAMAM树枝状大分子的伯胺和叔胺之间的静电相互作用。灯盏花素的药代动力学参数Cmax和AUC0-8 h分别为(119.65±9.36) ng·mL-1和(370.09±63.08) ng·h·mL-1。对于灯盏花素与PAMAM树枝状大分子的混合物,Cmax和AUC0-8 h分别为(518.17±17.07) ng·mL-1和(1219.47±201.87) ng·h·mL-1。灯盏花素与灯盏花素和PAMAM树枝状大分子混合物之间的AUC0-8 h存在显著差异(P<0.01)。PAMAM树枝状大分子可显著提高灯盏花素在水中的溶解度,并能显著改善灯盏花素的口服生物利用度。

相似文献

1
[The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].聚酰胺-胺(PAMAM)树枝状大分子对灯盏花素溶解度和药代动力学的影响
Yao Xue Xue Bao. 2009 Feb;44(2):197-202.
2
Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.树枝状聚合物作为潜在的药物载体。第一部分。在聚酰胺胺树枝状聚合物存在下非甾体抗炎药的增溶作用。
Eur J Med Chem. 2005 Nov;40(11):1188-92. doi: 10.1016/j.ejmech.2005.06.010. Epub 2005 Sep 8.
3
[Pharmacokinetics of breviscapine and its beta-cyclodextrin complex in rats].灯盏花素及其β-环糊精包合物在大鼠体内的药代动力学
Yao Xue Xue Bao. 2005 Jun;40(6):563-7.
4
Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.聚酰胺-胺树枝状聚合物:提高葛根素溶解度和生物利用度的优良药物载体。
Pharm Dev Technol. 2013 Sep-Oct;18(5):1051-7. doi: 10.3109/10837450.2011.653822. Epub 2012 Feb 5.
5
Solubility of nicotinic acid in polyamidoamine dendrimer solutions.烟酸在聚酰胺胺树枝状大分子溶液中的溶解度。
Eur J Med Chem. 2005 Dec;40(12):1384-9. doi: 10.1016/j.ejmech.2005.08.001. Epub 2005 Oct 13.
6
Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.用作酮洛芬溶解度增强剂的聚酰胺-胺树枝状大分子。
Eur J Med Chem. 2005 Dec;40(12):1390-3. doi: 10.1016/j.ejmech.2005.08.002. Epub 2005 Oct 13.
7
In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.使用具有三甲酰基核心的聚酰胺胺树枝状大分子进行体外基因递送。
Biomacromolecules. 2005 Jan-Feb;6(1):341-50. doi: 10.1021/bm040060n.
8
The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine.聚酰胺-胺(PAMAM)树枝状大分子的代数大小和表面官能团对硝苯地平水溶性的影响。
Int J Pharm. 2004 Oct 13;284(1-2):133-40. doi: 10.1016/j.ijpharm.2004.07.006.
9
Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.聚酰胺 - 胺(PAMAM)树枝状大分子和环糊精对实际难溶的氯硝柳胺的水相增溶作用比较。
Int J Pharm. 2005 Nov 4;304(1-2):193-209. doi: 10.1016/j.ijpharm.2005.07.023. Epub 2005 Sep 27.
10
Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.以磺胺甲恶唑(SMZ)为模型药物评估聚酰胺-胺(PAMAM)树枝状大分子作为抗菌药物载体的性能。
Eur J Med Chem. 2007 Jan;42(1):93-8. doi: 10.1016/j.ejmech.2006.07.015. Epub 2006 Nov 7.

引用本文的文献

1
Synthesis of Polyamidoamine Dendrimer for Encapsulating Tetramethylscutellarein for Potential Bioactivity Enhancement.用于包裹黄芩苷以增强潜在生物活性的聚酰胺-胺树枝状大分子的合成。
Int J Mol Sci. 2015 Nov 4;16(11):26363-77. doi: 10.3390/ijms161125956.